| Bentley, Kirsten  ORCID: https://orcid.org/0000-0002-6619-2098 and Stanton, Richard J.  ORCID: https://orcid.org/0000-0002-6799-1182
      2021.
      
      Hydroxypropyl methylcellulose-based nasal sprays effectively inhibit in vitro SARS-CoV-2 infection and spread.
      Viruses
      13
      
        (12)
      
      
      , 2345.
      10.3390/v13122345   | 
| ![viruses-13-02345.pdf [thumbnail of viruses-13-02345.pdf]](https://orca.cardiff.ac.uk/style/images/fileicons/application_pdf.png) | PDF
 - Published Version Available under License Creative Commons Attribution. Download (1MB) | 
Abstract
The ongoing coronavirus disease (COVID-19) pandemic has required a variety of non-medical interventions to limit the transmission of the causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One such option is over-the-counter nasal sprays that aim to block virus entry and transmission within the nasal cavity. In this study, we assessed the ability of three hydroxypropyl methylcellulose (HPMC)-based powder nasal sprays, produced by Nasaleze, to inhibit SARS-CoV-2 infection and release in vitro. Upon application, the HPMC powder forms a gel-like matrix within the nasal cavity—a process we recapitulated in cell culture. We found that virus release from cells previously infected with SARS-CoV-2 was inhibited by the gel matrix product in a dose-dependent manner, with virus levels reduced by >99.99% over a 72 h period at a dose of 6.4 mg/3.5 cm2. We also show that the pre-treatment of cells with product inhibited SARS-CoV-2 infection, independent of the virus variant. The primary mechanism of action appears to be via the formation of a physical, passive barrier. However, the addition of wild garlic provided additional direct antiviral properties in some formulations. We conclude that HPMC-based nasal sprays may offer an additional component to strategies to limit the spread of respiratory viruses, including SARS-CoV-2
| Item Type: | Article | 
|---|---|
| Date Type: | Publication | 
| Status: | Published | 
| Schools: | Schools > Medicine Research Institutes & Centres > Systems Immunity Research Institute (SIURI) | 
| Additional Information: | This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). | 
| Publisher: | MDPI | 
| ISSN: | 1999-4915 | 
| Funders: | Industrial | 
| Date of First Compliant Deposit: | 8 December 2021 | 
| Date of Acceptance: | 18 November 2021 | 
| Last Modified: | 16 May 2023 16:09 | 
| URI: | https://orca.cardiff.ac.uk/id/eprint/145891 | 
Citation Data
Cited 7 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
|  | Edit Item | 

 
							

 Dimensions
 Dimensions Dimensions
 Dimensions